We will be the First Mover to achieve globalization of Korean pharmaceutical companies.

  • Hello. Dear my Fellow
    I'm Jun Yong-soo, CEO of UNDBIO.
    It has been 10 years since we started pharmaceutical wholesale business and CSO business in 2010.
    Like the meaning of our company name ("UND" in German mean "AND" in English: mean for "CONTINUED MOVING"), our company has been a decade of constant challenges and growth despite many difficulties for congested domestic competitors.
    I would like to express my deepest gratitude to all the people in the medical and pharmaceutical business clients who have remembered and always supported our company.

    Now it's been 10 years since I started my company.
    While looking at the ups and downs of domestic pharmaceutical companies, I have deeply considered why aren't there any Korean pharmaceutical companies can expand to overseas market? I've always felt sorry for it, but now to achieve my unchangeable dream, I've faced a tough challenge to establish a qualified pharmaceutical company in Korea and build-up a global GMP standard pharmaceutical company to enter global pharma market.

    Our company will concentrate to be able to show you the reality of the Global GMP pharmaceutical factory till 2022.
    In 2023, we want to become the first pharmaceutical company like as "First Mover" can penetrate global pharmaceutical market, has market potential more than USD 1.7 trillion, and we will reveal the name of UNDBIO to the leading global pharmaceutical companies list.

    Once again, please remember our company name, UNDBIO and please watch the journey of our company achievement and expect your intensive support.

    Thank you.

    CEO Jun Yong Soo